Disclosures for "Efficacy of Cyclooxygenase-2 Inhibitors for Headache in Acute Brain Injury: A Systematic Review"
-
Dr. Martins Frota has nothing to disclose.
-
Dr. Khaliq has nothing to disclose.
-
Dr. Meza Comparan has nothing to disclose.
-
Dr. Pomar Forero has nothing to disclose.
-
Dr. Ahmad has nothing to disclose.
-
Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
-
Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. The institution of Dr. Busl has received research support from University of Florida Self Insurance Program. The institution of Dr. Busl has received research support from National Institutes of Health. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Editorial Board Member with Neurocritical Care that is relevant to AAN interests or activities.